The histone deacetylase inhibitor, suber
✍
Lisa M. Butler; Vasilios Liapis; Stelios Bouralexis; Katie Welldon; Shelley Hay;
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
French
⚖ 958 KB
## Abstract While the apoptosis‐inducing ligand Apo2L/TRAIL is a promising new agent for the treatment of cancer, the sensitivity of cancer cells for induction of apoptosis by Apo2L/TRAIL varies considerably. Identification of agents that can be used in combination with Apo2L/TRAIL to enhance apopt